Aktuelle Konzepte der nicht chirurgischen Parodontitistherapie

Trotz eines hohen Erkrankungsbefalls werden Patienten mit entzündlichen Parodontalerkrankungen nur unzureichend versorgt. Die meisten Parodontitiden können durch den Allgemeinzahnarzt erfolgreich behandelt werden. Grundlage ist zunächst eine antiinfektiöse Therapie durch eine subgingivale Instrumentierung mit Entfernung des Biofilms und von Konkrementen. Eine adjuvante Verabreichung von systemischen oder lokal wirksamen antimikrobiellen Medikamenten kann dies in bestimmten Fällen unterstützen.

Publication History

Article published online:
16 February 2021

• Literatur

• 1 Eke PI, Dye BA, Wei L. et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012; 91: 914-920
• 2 Jordan AR, Micheelis W. Fünfte Deutsche Mundgesundheitsstudie (DMS V), Materialienreihe Band 35. Köln: Deutscher Ärzteverlag; 2016
• 3 Glockmann E, Panzner K-D, Huhn P, Sigusch BW, Glockmann K. Ursachen des Zahnverlustes in Deutschland-Dokumentation einer bundesweiten Erhebung (2007). Köln: IDZ, Institut der Deutschen Zahnärzte; 2011
• 4 Kassenzahnärztliche Bundesvereinigung. KZBV Jahrbuch 2019. Statistische Basisdaten zur vertragszahnärztlichen Versorgung. Köln: Kassenzahnärztliche Bundesvereinigung; 2019
• 5 Kassenzahnärztliche Bundesvereinigung (KZBV), Bundeszahnärztekammer (BZÄK). Hrsg. PAR-Versorgungskonzept.Konzept für die Behandlung von Parodontalerkrankungen bei Versicherten der Gesetzlichen Krankenversicherung. Köln: KZBV; 2017
• 6 The American Academy of Periodontology. Consensus Report: Discussion Section I. In: Proceedings of the Workshop in Clinical Periodontics. Chicago: The American Academy of Periodontology; 1989: I-23-I-30
• 7 Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996; 1: 821-878
• 8 The American Academy of Periodontology. Parameters on chronic periodontitis with slight to moderate loss of periodontal support. J Periodontol 2000; 71: 853-855
• 9 American Academy of Periodontology. Parameter on Chronic Periodontitis With Advanced Loss of Periodontal Support. J Periodontol 2000; 71: 856-858
• 10 Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994; 5: 78-111 doi:10.1111/j.1600-0757.1994.tb00020.x
• 11 Marsh PD, Zaura E. Dental plaque biofilm: ecological interactions in health and disease. J Clin Periodontol 2017; 44 (Suppl. 18) 12-22
• 12 Socransky SS, Haffajee AD, Cugini MA. et al. Microbialcomplexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-144
• 13 Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996; 1: 821-878
• 14 Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997; 14: 9-11
• 15 Kebschull M, Demmer RT, Papapanou PN. “Gum bug, leave my heart alone!” Epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 2010; 89: 879-902
• 16 Buhlin K, Mantyla P, Paju S. et al. Periodontitis is associated with angiographically verified coronary artery disease. J Clin Periodontol 2011; 38: 1007-1014
• 17 Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes-systematic review. J Clin Periodontol 2013; 40 (Suppl. 14) 181-194
• 18 Preshaw PM, Alba AL, Herrera D. et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012; 55: 21-31
• 19 Michalowicz BS, Diehl SR, Gunsolley JC. et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Clin Periodontol 2000; 71: 1699-1707
• 20 Ronderos M, Ryder MI. Risk assessment in clinical practice. Periodontol 2000 2004; 34: 120-135
• 21 Schäfer AS, Van der Velden U, Laine ML. et al. Genetic susceptibility to periodontal disease: new insights and challenges. In: Lindhe J, Lang NP. eds. Clinical Periodontology and Implant Dentistry. 6th ed. Chichester, UK: Wiley Blackwell; 2015: 290-310
• 22 Van Dyke TE, Levine MJ, Tabak LA. et al. Reduced chemotactic peptid binding in juvenile periodontitis: a model for neutrophil function. Biochem Biophys Res Commun 1981; 100: 1278-1284
• 23 Gorlin RJ, Sedano H, Anderson VE. The syndrome of palmar-plantar hyperkeratosis and premature periodontal destruction of the teeth. A clinical and genetic analysis of the Papillon-Lefèvre syndrome. J Pediatr 1964; 65: 895-908
• 24 Hart TC, Hart PS, Michalec MD. et al. Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation. J Med Genet 2000; 37: 95-101
• 25 Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003; 14: 430-449
• 26 Kornman KS, Crane A, Wang HY. et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72-77
• 27 Rawlinson A, Dalati MHN, Rahman S. et al. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000; 27: 738-743
• 28 Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996; 67: 1041-1049
• 29 Grossi SG, Zambon JJ, Ho AW. et al. Assessment of risk for periodontal disease. I. Risk indicators, for attachment loss. J Periodontol 1994; 65: 260-267
• 30 Grossi SG, Genco RJ, Machtei EE. et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66: 23-29
• 31 American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005; 28 (Suppl. 01) S37-S42
• 32 Fletcher B, Gulanick M, Lamendola C. Risk Factors for Type 2 Diabetes Mellitus. J Cardiovasc Nurs 2002; 16: 17-23
• 33 Icks A, Rathmann W, Rosenbauer J, Giani G. Gesundheitsberichterstattung des Bundes – Heft 24. Diabetes mellitus. Berlin: Robert Koch-Institut; 2005. Im Internet (Stand: 14.03.2005): http://edoc.rki.de/documents/rki_fv/ren4T3cctjHcA/PDF/%2020Vo4CXYDBpeQ_47.pdf
• 34 Mealey BL, Oates TW. Diabetes Mellitus and Periodontal Diseases. J Periodontol 2006; 77: 1289-1303
• 35 Kaur G, Holtfreter B, Rathmann W. et al. Association between type 1 and type 2 diabetes with periodontal disease and tooth loss. J Clin Periodontol 2009; 36: 765-774
• 36 Safkan-Seppälä B, Ainamo J. Periodontal conditionsin insulin-dependent diabetes mellitus. J Clin Periodontol 1992; 19: 24-29
• 37 Taylor GW, Burt BA, Becker MP. et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998; 69: 76-83
• 38 NCHS, National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III), 1988 – 1994. Centers for Disease Control, public use data file no. 7 – 0627. Hyattsville/Maryland: Centers for Disease Control; 1997
• 39 Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192
• 40 Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27: 677-681
• 41 Mowat AG, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621-627 doi:10.1056/NEJM197103252841201
• 42 Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 1986; 63: 478-484
• 43 Brownlee M, Cerami A, Vlassara H. Advanced products glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1988; 4: 437-451
• 44 Lien YH, Stern R, Fu JC. et al. Inhibition of collagen fibril formation in vitro and subsequent cross-linking by glucose. Science 1984; 28: 1489-1491
• 45 Seibold JR, Uitto J, Dorwart BB. et al. Collagen synthesis and collagenase activity in dermal fibroblasts from patients with diabetes mellitus and digital sclerosis. J Lab Clin Med 1985; 105: 664-667
• 46 Salvi GE, Collins JG, Yalda B. et al. Monocytic TNF-α secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997; 24: 8-16 doi:10.1111/j.1600-051x.1997.tb01178.x
• 47 Salvi GE, Yalda B, Collins JG. et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997; 68: 127-135
• 48 Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013; 40 (Suppl. 14) 113-134
• 49 Fahey TJ, Sadaty A, Jones WG. et al. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991; 50: 308-313
• 50 Borgnakke WS, Ylöstalo PV, Taylor GW. et al. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Periodontol 2013; 84 (4 Suppl.): S135-S152
• 51 Magnusson I, Walker CB. Refractory periodontitis or recurrence of disease. J Clin Periodontol 1996; 23 (3 Pt 2): 289-292
• 52 Albandar JM, Streckfus CF, Adesanya MR. et al. Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 2000; 71: 1874-1881
• 53 Nociti FH, Casati MZ, Duarte PM. Current perspective of the impact of smoking on the progression and treatment of periodontitis. Periodontol 2000 2015; 67: 187-191
• 54 Kenney EB, Kraal JH, Saxe SR. et al. The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodontal Res 1977; 12: 227-234
• 55 Ryder MI, Fujitaki R, Lebus S. et al. Alterations of neutrophil L-selection and CD 18 expression by tobacco smoke: implications for periodontal diseases. J Periodontal Res 2006; 33: 359-368
• 56 Wendell KJ, Stein SH. Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol 2001; 72: 1038-1044
• 57 Mirbod SM, Abing SL, Pruthi VK. Immunohistochemical study of vestibular gingival blood vessel density and internal circumference in smokers and non-smokers. J Periodontol 2001; 72: 1318-1323
• 58 Caton JG, Armitage G, Berglundh T. et al. A new classification scheme for periodontal and peri-implant diseases and conditions – Introduction and key changes from the 1999 classification. J Clin Periodontol 2018; 45 (Suppl. 20) S1
• 59 Landi L, Amar S, Polins AS. et al. Host mechanisms in the pathogenesis of periodontal disease. Curr Opin Periodontol 1997; 4: 3-10
• 60 Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol 1991; 18: 411-420
• 61 Schenkein HA, Van Dyke TE. Early-onset periodontitis: systemic aspects of etiology and pathogenesis. Periodontol 2000 1994; 6: 7-25
• 62 Renvert S, Wikström M, Dahlén G. et al. On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets. J Clin Periodontol 1990; 17: 351-355
• 63 The American Academy of Periodontology. Position Paper: Systemic Antibiotics in Periodontics. J Periodontol 2004; 75: 1553-1565
• 64 Eickholz P. Parodontale Therapie mit lokalen Antibiotika. Das Dental Vademekum. ZM online 2010. Im Internet (Stand: 16.06.2010): https://www.zm-online.de/archiv/2010/12/zahnmedizin/parodontale-therapie-mit-lokalen-antibiotika/
• 65 Schlagenhauf U. Adjuvante systemische Antibiotikagabe bei subgingivaler Instrumentierung im Rahmen der systematischen Parodontitistherapie. Die neuen S3 Leitlinien Parodontitistherapie. Deutsche Gesellschaft für Parodontologie. Frankfurt 2018. Im Internet (Stand: 12.11.2018): https://www.awmf.org/leitlinien/detail/ll/083-029.html
• 66 Lang NP, Tonetti MS. Periodontal Risk Assessment (PRA) for Patients in Supportive Periodontal Therapy (SPT). Oral Health Prev Dent 2003; 1: 7-16
• 67 Bürgerliches Gesetzbuch § 630e. Februar 2013.
• 68 Bharathi DM, Cobb CM. 7 Steps to the Nonsurgical Treatment of Periodontitis. Dimens Dent Hyg 2018; 16: 39-42
• 69 Sanz M, Herrera D, Kebschull M. et al. Treatment of stage I–III periodontitis – The EFP S3 level clinical practice guideline. Clin Periodontol 2020; 47 (Suppl. 22) 4-60 doi:10.1111/jcpe.13290
• 70 Lertpimonchai A, Rattanasiri S, Arj-Ong Vallibhakara S. et al. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. Int Dent J 2017; 67: 332-343
• 71 Haffajee AD, Socransky SS. JC Gunsolley. Anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003; 8: 115-181
• 72 van Winkelhoff AJ, Winkel EG. Antibiotics in Periodontics: Right or Wrong?. J Periodontol 2009; 80: 1555-1558
• 73 Eickholz P, Koch R, Kocher T. et al. Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patientsʼ age: An exploratory sub-analysis of the ABPARO trial. J Clin Periodontol 2019; 46: 491-501
• 74 Sanz M, Teughels W. Innovations in non-surgical periodontal therapy: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008; 35 (8 Suppl.): 3-7
• 75 Lang NP, Suvan JE, Tonetti MS. Risk factor assessment tools for the prevention of periodontitis progression a systematic review. J Clin Periodontol 2015; 42 (Suppl. 16) S59-S70
• 76 Rentiert S, Badegästen A, Niles R. Healing after treatment of periodontal intraosseous defects I. Comparative study of clinical methods. J Clin Periodontol 1981; 8: 387-399
• 77 Badersten A, Nilvéus R, Egelberg J. Effect of non-surgical periodontal therapy. J Clin Periodontol 1985; 12: 190-200
• 78 Badersten A, Nilvéus R, Egelberg J. Effect of nonsurgical periodontal therapy. V. Patterns of probing attachment loss in non-responding sites. J Clin Periodontol 1985; 12: 270-282 doi:10.1111/j.1600-051x.1985.tb02293.x
• 79 Badersten A, Nilvéus R, Egelberg J. Effect of non-surgical periodontal therapy. J Clin Periodontol 1985; 12: 351-359
• 80 Newman MG. Proceedings of the 1966 World Workshop in Periodontics. American Academy of Periodontology. Ann Periodontol 1996; 1: 1-947
• 81 Schroeder HE. Pathobiologie oraler Strukturen: Zähne, Pulpa, Parodont. Freiburg i. B.: Karger; 1996
• 82 Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996; 1: 621-666
• 83 Stahl SS, Slavkin HC, Yamada L. et al. Speculations about gingival repair. J Periodontol 1972; 43: 395-402
• 84 Cole RT, Crigger M, Bogle G. et al. Connective tissue regeneration to periodontally diseased teeth. A histological study. J Periodontal Res 1980; 15: 1-9
• 85 Narayanan AS, Page RC. Connective tissues of the periodontium: a summary of current work. Coll Relat Res 1983; 3: 33-64
• 86 Cichon P. Alveoläre Knochenneubildung nach geschlossener Taschentherapie. ZWP spezial 2015; 10: 4-8
• 87 Rabbani GM, Ash MM, Caffesse RG. The effectiveness of subgingival scaling and root planing in calculus removal. J Periodontol 1981; 52: 119-123
• 88 Eickholz P. Glossar der Grundbegriffe für die Praxis: Unterstützende Parodontitistherapie (UPT). Teil 1: Ziele und Inhalte. Parodontologie 2007; 18: 165-170
• 89 Betsy J, Prasanth CS, Baiju KV. et al. Efficacy of antimicrobial photodynamic therapy in the management of chronic periodontitis: a randomized controlled clinical trial. J Clin Periodontol 2014; 41: 573-581
• 90 Dragoo MR. A clinical evaluation of hand and ultrasonic instruments on subgingival debridement. 1. With unmodified and modified ultrasonic inserts. Int J Periodontics Restorative Dent 1992; 12: 310-323
• 91 Takacs VJ, Lie T, Perala DG. et al. Efficacy of 5 machining instruments in scaling of molar furcations. J Periodontol 1993; 64: 228-236
• 92 Greenstein G. Periodontal Diseases are Curable. J Periodontol 2002; 73: 950-953
• 93 Schenkein HA. Finding genetic risk factors for periodontal diseases: is the climb worth the view?. Periodontol 2000 2002; 30: 79-90
• 94 Suvan J, Leira Y, Sancho FMM. et al. Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol 2020; 47: 155-175